These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Effectiveness of dual cyclooxygense and leukotriene blockade with ibuprofen and LY203647 during canine endotoxic shock. Passmore JC, Jimenez AE. Circ Shock; 1993 Jan; 39(1):21-8. PubMed ID: 8481974 [Abstract] [Full Text] [Related]
11. Effect of the LTD4 receptor antagonist LY203647 on endotoxic shock sequelae in the rat. Li EJ, Cook JA, Ashton S, Wise WC, Halushka PV. Eur J Pharmacol; 1991 Jun 25; 199(2):221-5. PubMed ID: 1954979 [Abstract] [Full Text] [Related]
12. Hemodynamic and renal advantages of dual cyclooxygenase and leukotriene blockade during canine endotoxic shock. Young JS, Passmore JC. Circ Shock; 1990 Nov 25; 32(3):243-55. PubMed ID: 2175681 [Abstract] [Full Text] [Related]
13. The effect of an orally active leukotriene D4/E4 antagonist, LY171883, on antigen-induced airway responses in allergic sheep. Abraham WM, Wanner A, Stevenson JS, Chapman GA. Prostaglandins; 1986 Mar 25; 31(3):457-67. PubMed ID: 3754973 [Abstract] [Full Text] [Related]
14. Beneficial effects of LY203647, a novel leukotriene C4/D4 antagonist, on pulmonary function and mesenteric perfusion in a porcine model of endotoxic shock and ARDS. Cohn SM, Kruithoff KL, Rothschild HR, Wang HL, Antonsson JB, Fink MP. Circ Shock; 1991 Jan 25; 33(1):7-16. PubMed ID: 2009603 [Abstract] [Full Text] [Related]
15. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock. Hock CE, Lefer AM. Circ Shock; 1985 Jan 25; 17(4):263-72. PubMed ID: 3841503 [Abstract] [Full Text] [Related]
16. Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects. Phillips GD, Rafferty P, Robinson C, Holgate ST. J Pharmacol Exp Ther; 1988 Aug 25; 246(2):732-8. PubMed ID: 3404455 [Abstract] [Full Text] [Related]
17. Concentration-dependent, stereoselective inhibition of the endotoxin-induced hemoconcentration in conscious rats with the peptidoleukotriene receptor antagonist SK & F 104353. Smith EF, Kinter LB, Jugus M, Eckardt RD, Newton JF. Eicosanoids; 1989 Aug 25; 2(2):101-7. PubMed ID: 2560662 [Abstract] [Full Text] [Related]
18. The improvement in endotoxin-induced redistribution of organ blood flow by inhibition of thromboxane and prostaglandin synthesis. Tempel GE, Cook JA, Wise WC, Halushka PV. Adv Shock Res; 1982 Aug 25; 7():209-18. PubMed ID: 6753535 [No Abstract] [Full Text] [Related]
19. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat. Toth PD, Mikulaschek AW. Circ Shock; 1986 Aug 25; 20(3):193-203. PubMed ID: 3802423 [Abstract] [Full Text] [Related]
20. Endotoxemia in rats--influence of lipoxygenase blocker versus leukotriene receptor antagonist (BW755C vs LY171883). Bahrami S, Paul E, Redl H, Schlag G, Mihm F. Prog Clin Biol Res; 1988 Aug 25; 272():283-92. PubMed ID: 2839854 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]